Assignee
ORBUS THERAPEUTICS INC
US·2 granted patents·5 pending applications·3 citations·filing 2016–2024
Top patents by PatentIndex Score
7 records- 0182US10786470B2Formulations for administration of eflornithineORBUS THERAPEUTICS INC·Filed 2017·Granted Sep 29, 2020·2 cites·10 claims
- 0278US11439612B2Formulations for administration of eflornithineORBUS THERAPEUTICS INC·Filed 2020·Granted Sep 13, 2022·1 cites·16 claims
- 0373US2025041256A1Compositions and methods for use of eflornithine and derivatives and analogs thereof to treat cancers, including gliomasORBUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0472US2023338317A1Formulations for administration of eflornithineORBUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0556US2019091187A1Compositions and methods for use of eflornithine and derivatives and analogs thereof to treat cancers including gliomasORBUS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 0654US2017273926A1Compositions and methods for use of eflornithine and derivatives and analogs thereof to treat cancers, including gliomasORBUS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 0745US2019133985A1Compositions and methods for use of eflornithine and derivatives and analogs thereof to treat cancers, including gliomasORBUS THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →